神曲消食口服液治疗小儿轮状病毒感染性腹泻的疗效观察

doi:10.11958/20240945

摘要/Abstract

摘要：

目的探讨神曲消食口服液联合喜炎平治疗小儿轮状病毒感染性腹泻的疗效及对免疫功能的影响。方法将200例轮状病毒感染性腹泻患儿按照治疗方法均分为2组，对照组患儿予以喜炎平治疗，试验组患儿予以神曲消食口服液联合喜炎平治疗，比较2组治疗效果及对患儿炎性因子及免疫功能的影响。结果试验组临床总有效率高于对照组（P<0.05）；治疗后，试验组患儿中医证候积分、血清白细胞介素（IL）-6、肿瘤坏死因子（TNF）-α、干扰素（INF）-γ、超敏C-反应蛋白（hs-CRP）水平及CD8⁺水平均低于对照组（P<0.05），血清CD3⁺、CD4⁺及CD4⁺/CD8⁺水平均高于对照组（P<0.05）。试验组患儿止泻时间早于对照组，轮状病毒转阴率高于对照组（P<0.05）。结论神曲消食口服液联合喜炎平治疗小儿轮状病毒感染性腹泻能快速缓解患儿症状，减轻炎症反应，提高免疫功能。

关键词: 轮状病毒感染, 腹泻, 免疫, 儿童，学龄, 神曲消食口服液, 喜炎平

Abstract:

Objective To explore the therapeutic effect of Shenqu Xiaoshi oral liquid combined with Xiyanping on children with rotavirus infected diarrhea and its impact on immune function. Methods A total of 200 children with rotavirus infected diarrhea were diveded into two groups according to treatment methods. The control group was treated with Xiyanping. The experimental group was treated with Shenqu Xiaoshi oral liquid combined with Xiyanping. The therapeutic effects and impacts on inflammatory factors and immune function were compared between the two groups. Results The total effective rate of clinical efficacy was higher in the experimental group than that in the control group (P<0.05). After treatment, traditional Chinese medicine (TCM) syndrome scores, serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interferon-γ (INF-γ), hypersensitive C-reactive protein (hs-CRP) and CD8⁺ were lower in the experimental group than those in the control group (P<0.05), the serum levels of CD3⁺, CD4⁺and CD4⁺/CD8⁺ were higher than those of the control group (P<0.05). The antidiarrheal time was earlier in the experimental group than that of the control group (P<0.05), and the negative rate of stool rotavirus was higher than that of the control group (P<0.05). Conclusion The combination of Shenqu Xiaoshi oral liquid and Xiyanping in the treatment of children with rotavirus infected diarrhea can quickly relieve symptoms of children, reduce inflammatory reactions and improve immune function.

Key words: rotavirus infections, diarrhea, immunity, child, preschool, Shenqu Xiaoshi oral liquid, Xiyanping

中图分类号:

R725.7，R512.5

图/表 5

参考文献 21

[1]	HUA S. Clinical value of zinc combined with folic acid in the treatment of infantile diarrhea[J]. Minerva Gastroenterol(Torino), 2024, 70(3):383-385. doi:10.23736/S2724-5985.23.03516-7.
[2]	中华中医药学会儿科分会, 中华中医药学会中药临床药理分会. 小儿腹泻中药临床试验设计与评价技术指南[J]. 药物评价研究, 2020, 43(4):660-664.
	Pediatric Branch of China Association of Chinese Medicine, Chinese Medicine Clinical Pharmacology Branch of China Association of Chinese Medicine. Guideline on design and evaluation of clinical trials for Chinese medicine in common pediatric disease:Diarrhea[J]. Drug Evaluation Research, 2020, 43(4):660-664. doi:10.7501/j.issn.1674-6376.2020.04.013.
[3]	徐嘉辉, 张畅, 陈丽君, 等. 脾胃康颗粒口服联合中药热敷辅助治疗小儿轮状病毒感染性腹泻脾虚湿热证40例临床观察[J]. 中医儿科杂志, 2022, 18(3):49-53.
	XU J H, ZHANG C, CHEN L J, et al. Clinical observation on 40 cases of pediatric rotavirus-induced diarrhea with damp-heat due to spleen-asthenia syndrome treated by oral administration of Piweikang Keli combined with Chinese materia medica fomentation as adjuvant therapy[J]. J Pediatrics TCM, 2022, 18(3):49-53. doi:10.16840/j.issn1673-4297.2022.03.15.
[4]	史卜文, 李利寻, 谢雁鸣, 等. 真实世界喜炎平注射液治疗3846例细菌性肠道感染患者临床用药特征分析[J]. 中国药物警戒, 2023, 20(9):1017-1021,1026.
	SHI B W, LI L X, XIE Y M, et al. Clinical characteristics of Xiyanping injection in 3846 patients with bacterial intestinal infection in the real world[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9):1017-1021,1026. doi:10.19803/j.1672-8629.20220061.
[5]	陈词. 神曲消食口服液治疗小儿腹泻的效果及对炎症因子水平的影响[J]. 中国现代药物应用, 2023, 17(12):95-97.
	CHEN C. Effect of Shenqu Xiaoshi Oral Liquid on the treatment of diarrhea in children and its influence on the level of inflammatory factors[J]. Chin J Mod Drug Appl, 2023, 17(12):95-97. doi:10.14164/j.cnki.cn11-5581/r.2023.12.026.
[6]	江载芳, 申昆玲, 沈颖. 诸福棠实用儿科学[M]. 8版. 北京: 人民卫生出版社, 2015:941-949.
	JIANG Z F, SHEN K L, SHEN Y. Zhu Futang Practical Pediatrics[M]. 8th Ed. Beijing: People's Medical Publishing House, 2015:941-949.
[7]	中华中医药学会儿科分会临床评价学组. 小儿轮状病毒性肠炎中药新药临床试验设计与评价技术指南[J]. 药物评价研究, 2015, 38(4):350-356.
	Clinical Evaluation Unit, Pediatric Branch of China Association for Traditional Chinese Medicine. Guideline on evaluation of Chinese medical research for treatment of rotavirus gastroenteritis in children[J]. Drug Evaluation Research, 2015, 38(4):350-356. doi:10.7501/j.issn.1674-6376.2015.04.002.
[8]	LAKER G, NANKUNDA J, MELVIS B M, et al. Prevalence and factors associated with rotavirus diarrhea among children aged 3-24 months after the introduction of the vaccine at a referral hospital in Uganda:a cross-sectional study[J]. BMC Pediatr, 2024, 24(1):358. doi:10.1186/s12887-024-04842-8.
[9]	王明雯, 李静欣, 高升辉, 等. 2019年我国5岁以下腹泻住院患儿A组轮状病毒感染的流行特征分析[J]. 中华实验和临床病毒学杂志, 2022, 36(2):172-175.
	WANG M W, LI J X, GAO S H, et al. Epidemiological characteristics of group A rotavirus infection in hospitalized children under 5 years of age with diarrhea in China in 2019[J]. Chinese Journal of Experimental and Clinical Virology, 2022, 36(2):172-175. doi:10.3760/cma.j.cn112866-20211230-00217.
[10]	徐秀营, 王绍杰. 布拉氏酵母菌散联合蒙脱石散治疗小儿轮状病毒感染性腹泻的效果及对免疫功能的影响[J]. 临床医学研究与实践, 2022, 7(18):80-82.
	XU X Y, WANG S J. Effect of Saccharomyces boulardii sachets combined with montmorillonite powder on Rotavirus infectious diarrhea in children and its influence on immune function[J]. Clinical Research and Practice, 2022, 7(18):80-82. doi:10.19347/j.cnki.2096-1413.202218022.
[11]	张旭, 李玢, 陈海根, 等. 利巴韦林单用与联用喜炎平注射液治疗轮状病毒肠炎患儿的疗效对比的Meta分析[J]. 中外医疗, 2023, 42(14):129-133.
	ZHANG X, LI F, CHEN H G, et al. Meta-analysis of the efficacy of ribavirin alone and combination with Xi-yanping injection in the treatment of children with rotavirus enteritis[J]. China & Foreign Medical Treatment, 2023, 42(14):129-133. doi:10.16662/j.cnki.1674-0742.2023.14.129.
[12]	中国中西医结合学会儿科分会消化学组. 神曲消食口服液临床应用指导意见(2021-08-30)[J]. 世界中医药, 2021, 16(22):3265-3269.
	Gastroenterology Group of Pediatric Specialty Committees, China Society of Integrated Traditional Chinese and Western Medicine. Guidelines on clinical application of Shenqu Xiaoshi oral liquid(2021-08-30)[J]. World Chinese Medicine, 2021, 16(22):3265-3269. doi:10.3969/j.issn.1673-7202.2021.22.001.
[13]	文伟, 黄金华, 刘燕青, 等. 神曲消食口服液联合锌制剂佐治小儿腹泻50例疗效观察[J]. 药品评价, 2021, 18(1):44-47.
	WEN W, HUANG J H, LIU Y Q, et al. Observation on the curative effect of Shenqu Xiaoshi Oral liquid combined with zinc preparation in the treatment of 50 cases of infantile diarrhea[J]. Drug Evaluation, 2021, 18(1):44-47. doi:10.19939/j.cnki.1672-2809.2021.01.13.
[14]	宁启国, 陈娜. 双歧杆菌四联活菌联合干扰素对轮状病毒感染性腹泻患儿炎性因子、免疫功能与肠道菌群的影响[J]. 延安大学学报(医学科学版), 2023, 21(2):83-86.
	NING Q G, CHEN N. Effects of bifidobacterium tetravaccine live combined with interferon on inflammatory factors,immune function and intestinal flora in children with rotavirus infectious diarrhea[J]. Journal of Yanan University(Medical Sciences), 2023, 21(2):83-86. doi:10.19893/j.cnki.ydyxb.2023-0066.
[15]	路钰夏, 杨辉, 王向辉, 等. 病毒感染性腹泻对儿童人群肠道菌群及IL-6、TNF-α、hs-CRP、IFN-γ水平的影响[J]. 中国实验诊断学, 2022, 26(6):842-846.
	LU Y X, YANG H, WANG X H, et al. Effect of virus-infected diarrhea on intestinal flora and levels of IL-6,TNF-α,hs-CRP and IFN-γ in children[J]. Chinese Journal of Laboratory Diagnosis, 2022, 26(6):842-846. doi:10.3969/j.issn.1007-4287.2022.06.014.
[16]	尚小玉, 聂楠. CRP、心肌酶谱、肝功能检测在小儿轮状病毒感染性腹泻诊治中的应用价值[J]. 贵州医药, 2021, 45(3):454-455.
	SHANG X Y, NIE N. Application value of CRP,myocardial enzyme profile and liver function detection in diagnosis and treatment of rotavirus infected diarrhea in children[J]. Guizhou Medicine, 2021, 45(3):454-455. doi:10.3969/j.issn.1000-744X.2021.03.061.
[17]	张根民. 神曲消食口服液治疗小儿腹泻的疗效及其对IL-6、TNF-α水平的影响[J]. 北方药学, 2019, 16(3):142-143.
	ZHANG G M. Effect of Shenqu Xiaoshi oral liquid on diarrhea in children and its effect on IL-6 and TNF-α levels[J]. Journal of Northern Medicine, 2019, 16(3):142-143. doi:10.3969/j.issn.1672-8351.2019.03.109.
[18]	吕立铭, 彭崇胜, 李晓波. 山楂核化学成分、药理作用及应用研究进展[J]. 沈阳药科大学学报, 2022, 39(12):1521-1532.
	LV L M, PENG C S, LI X B. Research progress in chemical ingredients,pharmacological activities and application of hawthorn seeds[J]. Journal of Shenyang Pharmaceutical University, 2022, 39(12):1521-1532. doi:10.14066/j.cnki.cn21-1349/r.2021.0772.
[19]	辛卫云, 白明, 苗明三. 麦芽的现代研究[J]. 中医学报, 2017, 32(4):613-615.
	XIN W Y, BAI M, MIAO M S. Modern study analysis on malt[J]. China Journal of Chinese Medicine, 2017, 32(4):613-615. doi:10.16368/j.issn.1674-8999.2017.04.160.
[20]	肖瑞瑶, 滕攀攀, 綦世金, 等. 党参多糖对肠道微生态及肠道疾病作用研究进展[J]. 微生物学通报, 2023, 50(2):687-696.
	XIAO R Y, TENG P P, QI S J, et al. Research progress in the effect of Codonopsis pilosula polysaccharide on intestinal microecology and intestinal diseases[J]. Microbiology China, 2023, 50(2):687-696. doi:10.13344/j.microbiol.china.220461.
[21]	左军, 祁天立, 胡晓阳. 茯苓化学成分及现代药理研究进展[J]. 中医药学报, 2023, 51(1):110-114.
	ZUO J, QI T L, HU X Y. Research progress in chemical constituents and modern pharmacology of Poria Cocos[J]. Acta Chinese Medicine and Pharmacology, 2023, 51(1):110-114. doi:10.19664/j.cnki.1002-2392.230022.

组别	n	显效	有效	无效	总有效
对照组	100	24（24.0）	58（58.0）	18（18.0）	82（82.0）
试验组	100	45（45.0）	49（49.0）	6（6.0）	94（94.0）
χ²					6.818^＊

组别	n	显效	有效	无效	总有效
对照组	100	24（24.0）	58（58.0）	18（18.0）	82（82.0）
试验组	100	45（45.0）	49（49.0）	6（6.0）	94（94.0）
χ²					6.818^＊

组别	治疗前	治疗后	t
对照组	14.13±3.72	7.65±2.12	15.606^＊
试验组	13.89±3.65	4.74±1.46	24.291^＊
t	0.461	11.288^＊

组别	治疗前	治疗后	t
对照组	14.13±3.72	7.65±2.12	15.606^＊
试验组	13.89±3.65	4.74±1.46	24.291^＊
t	0.461	11.288^＊

组别	n	止泻时间/h	轮状病毒转阴率
对照组	100	42.55±11.72	65（65.0）
试验组	100	29.62±8.74	88（88.0）
t或χ²		8.846^＊	14.713^＊